Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol. 1984 Oct;327(4):299-303. doi: 10.1007/BF00506240.
Changes in tension were monitored isometrically on spiral strips from human saphenous veins obtained during surgical removal of varicose veins. Concentration-response curves for noradrenaline and 5-hydroxytryptamine (5-HT) were established by cumulative administrations, curves for dihydroergotamine were constructed from the mean responses to single concentrations. The use of the antagonists prazosin, yohimbine and pizotifen provided evidence for the existence of both postjunctional alpha 1- and alpha 2-adrenoceptors and for the existence of 5-HT receptors. The venoconstrictor effects of dihydroergotamine were unchanged by prazosin. Yohimbine antagonized both dihydroergotamine and 5-HT at about 60 times higher concentrations than required against noradrenaline whereas pizotifen inhibited responses to both dihydroergotamine and 5-HT at about 100 times lower concentrations than those to noradrenaline. These new results are in contrast to conclusions drawn from animal studies and do not support the suggestion that in man the venoconstrictor activity of dihydroergotamine is mediated through stimulation of alpha-adrenoceptors. The present results strongly suggest that in human saphenous veins the constrictor activity of dihydroergotamine is mediated at least in part through stimulation of 5-HT receptors.
在手术切除静脉曲张时获取的人隐静脉螺旋条上,等长监测张力变化。通过累积给药建立去甲肾上腺素和5-羟色胺(5-HT)的浓度-反应曲线,二氢麦角胺的曲线则根据对单一浓度的平均反应构建。使用拮抗剂哌唑嗪、育亨宾和苯噻啶为存在节后α1和α2肾上腺素能受体以及5-HT受体提供了证据。哌唑嗪对二氢麦角胺的静脉收缩作用无影响。育亨宾拮抗二氢麦角胺和5-HT的浓度比对去甲肾上腺素所需浓度高约60倍,而苯噻啶抑制二氢麦角胺和5-HT反应的浓度比对去甲肾上腺素低约100倍。这些新结果与动物研究得出的结论相反,不支持二氢麦角胺在人体内的静脉收缩活性是通过刺激α肾上腺素能受体介导的这一观点。目前的结果强烈表明,在人隐静脉中,二氢麦角胺的收缩活性至少部分是通过刺激5-HT受体介导的。